Immunodeficiency, developmental delay, and hypohomocysteinemia: genes and variants
Explore variant evidence for Immunodeficiency, developmental delay, and hypohomocysteinemia across 1 analyzed protein (NFE2L2). Linked ClinVar records include 3 pathogenic or likely pathogenic variants, 11 variants of uncertain significance and 3 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Immunodeficiency, developmental delay, and hypohomocysteinemia
NFE2L2: Nuclear factor erythroid 2-related factor 2
It activates antioxidant, detoxification, and metabolic genes when released from KEAP1-mediated degradation. Somatic activating variants can lock cancer cells into a persistent stress-resistant state and promote therapy resistance.
3 ClinVar pathogenic / likely pathogenic and 14 uncertain variants in NFE2L2 have source records linked to Immunodeficiency, developmental delay, and hypohomocysteinemia. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Immunodeficiency, developmental delay, and hypohomocysteinemia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NFE2L2 G31R | 31 | DLG motif | Pathogenic / likely pathogenic |
| NFE2L2 E79K | 79 | ETGE motif | Pathogenic / likely pathogenic |
| NFE2L2 G81S | 81 | ETGE motif | Pathogenic / likely pathogenic |
Diseases related to Immunodeficiency, developmental delay, and hypohomocysteinemia
- Colorectal cancer, also linked to NFE2L2
- Lung cancer, also linked to NFE2L2
- Hepatocellular carcinoma, also linked to NFE2L2
- Head and neck squamous cell carcinoma, also linked to NFE2L2
Frequently asked questions
Which genes have records linked to Immunodeficiency, developmental delay, and hypohomocysteinemia?
This view contains 1 analyzed proteins: NFE2L2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 3 pathogenic or likely pathogenic variants, 11 variants of uncertain significance and 3 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 19 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center